Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeCeek Women's HealthCeek Women's Health and Lupin Sign a Marketing Agreement

Ceek Women’s Health and Lupin Sign a Marketing Agreement

Ceek Women’s Health (Ceek), the women-led, groundbreaking medical device company and Lupin Pharmaceuticals Inc., the US sales and marketing subsidiary of Lupin Limited (Lupin), announced an agreement to add the Nella women’s health products to Lupin’s promotional offering in the United States. Under the promotional arrangement, Lupin’s sales representatives will detail and demonstrate Ceek products including the Nella NuSpec (the Smarter Reusable Vaginal Speculum), VuSleeve, and VuLight products, alongside Lupin Women’s Health flagship product, Solosec® (secnidazole) 2g oral granules indicated for the treatment of bacterial vaginosis (BV), a common vaginal infection in adult women.16  

Offering the first meaningful update to the vaginal speculum in nearly 150 years, the Nella NuSpec which will launch shortly, is the result of extensive prototyping and research to change the patient experience during gynecological exams. The VuSleeve and the VuLight are accessories to the speculum designed to provide easy visualization and access to the cervix.  The Nella products are designed to improve the quality of care for all women as well as in specific segments, including adolescents, transgender patients, rape or trauma patients, post-menopausal women, and cancer survivors. Ceek has been the recipient of three prestigious product design awards including the 2020 Red Dot Award, the 2020 iF Award, and the 2019 Core77 Notable Design Award.

“We have dedicated ourselves to pioneering quality women’s health products that are transforming gynecological care and improving the exam experience for all patients,” said Fahti Khosrowshahi, CEO and Founder of Ceek. “We are very proud to partner with Lupin to introduce our products to their network of obstetricians and gynecologists, allowing us to offer more options to a greater range of patients than previously thought possible.” Jon Stelzmiller, President – Specialty Lupin Pharmaceuticals, Inc. added, “We share the same sentiment and commitment to women’s health as Ceek, making it that much more meaningful as we add these ground-breaking and innovative offerings to our providers and patients.”

Lupin Women’s Health flagship product, Solosec will also be a part of the offering. Solosec® 2g oral granules, a single-dose therapy for bacterial vaginosis (BV), the most common vaginal infection in the U.S., affecting more than 20 million women between the ages of 14 and 49 annually.

Solosec® was designed to be easy to take for patients with BV, with one oral dose containing a full course of treatment.[i] After one dose, Solosec® continues to treat BV for four days without any alcohol restriction – in vitro drug alcohol studies show Solosec® does not inhibit the enzyme that metabolizes alcohol.8 In a survey answered by 85 women who completed Solosec®  treatment, 9 out of 10 were satisfied, very satisfied, or extremely satisfied with the result of their Solosec® treatment, and would recommend to a friend with BV that they speak to their doctor about Solosec®.[ii]

To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceuticals, Inc. at  1-844-SOLOSEC (1-844-765-6732) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch

Full Prescribing Information Here.


References

[i] SOLOSEC® [prescribing information]. Baltimore, MD: Lupin Pharmaceuticals, Inc; 2017.

[ii] Data on file. Experience Program: Post Treatment Patient Survey data (May 2019-Sep 2019). Prepared September 2019. (LPSO-23506). Lupin Pharmaceuticals, Inc.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy